Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Mindfulness Based Application for Smoking Cessation
Brief Summary: Cigarette smoking is the leading cause of preventable death and disability in the world. Although over 70% of smokers want to quit, fewer than 5% achieve this goal annually. Additional effective, safe, and accessible treatments for nicotine dependence are needed due to the low abstinence rates (20-30%) achieved in behavioral therapies, the unappealing side effects of pharmacotherapy, and the frequent lack of accessibility to treatment. Recent evidence supports the central role of craving in maintaining nicotine dependence, and neither behavioral nor replacement therapies directly target the relationship between cravings and smoking. Mindfulness therapy has been found to be effective in teaching strategies to decouple the association between craving and smoking. Mindfulness based smoking therapy (MT) has preliminary support for reducing consumption in smokers, and Dr. Judson Brewer has recently translated this program into a mobile device application (app) for smoking cessation. With Dr. Brewer's consultation, we propose to assess the feasibility of implementation of a MT mobile application in local hospital and community clinics and the effectiveness of the MT mobile application compared to a National Cancer Institute (NCI) QuitPal behavioral change group. We will examine smoking results at end of treatment and 2 and 6 month follow-up as well as the role of craving. If MT smoking cessation is determined to be effective in a mobile phone application, this finding will be a significant step in providing an additional effective and safe treatment for smokers wishing to quit or cut down on their intake, and will be especially important in providing treatment options for marginalized or hard-to-access individuals wishing to reduce cigarette intake.


Options:
A: Arm Label: ACT Group 1; Type: EXPERIMENTAL; Interventions: Behavioral: Acceptance and Commitment Therapy, Drug: Varenicline | Arm Label: MBC Group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational and Behavioral Counseling, Drug: Varenicline | Intervention Type: BEHAVIORAL; Name: Acceptance and Commitment Therapy; Assigned to Arm(s): ACT Group 1 | Intervention Type: BEHAVIORAL; Name: Motivational and Behavioral Counseling; Assigned to Arm(s): MBC Group 2 | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): ACT Group 1, MBC Group 2
B: Arm Label: Mindfulness Based Relapse Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Based Relapse Prevention | Arm Label: Brazilian Ministry of Health Protocol; Type: OTHER; Interventions: Behavioral: Mindfulness Based Relapse Prevention, Other: Brazilian Ministry of Health Protocol | Intervention Type: BEHAVIORAL; Name: Mindfulness Based Relapse Prevention; Assigned to Arm(s): Brazilian Ministry of Health Protocol, Mindfulness Based Relapse Prevention | Intervention Type: OTHER; Name: Brazilian Ministry of Health Protocol; Assigned to Arm(s): Brazilian Ministry of Health Protocol
C: Arm Label: Mindfulness Based Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness based smoking cessation | Arm Label: Behavioral Smoking Cessation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral Smoking Cessation intervention | Intervention Type: BEHAVIORAL; Name: Mindfulness based smoking cessation; Assigned to Arm(s): Mindfulness Based Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Smoking Cessation intervention; Assigned to Arm(s): Behavioral Smoking Cessation
D: Arm Label: ACT; Type: EXPERIMENTAL; Interventions: Other: Acceptance & Commitment Therapy (ACT) | Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Other: Cognitive Behavioral Therapy (CBT) | Intervention Type: OTHER; Name: Acceptance & Commitment Therapy (ACT); Assigned to Arm(s): ACT | Intervention Type: OTHER; Name: Cognitive Behavioral Therapy (CBT); Assigned to Arm(s): CBT

Answer: C